BioSpace News Archive

Creabilis Receives Positive Feedback On CT327 From U.S. FDA, Providing Clear Path To Registration

January 12, 2015
·
3 min read
Drug Development

The Lancet Oncology Publishes Phase III Data Showing Giotrif® (Afatinib*) Significantly Extended Overall Survival Of Lung Cancer Patients With The Most Common EGFR Mutation Over Chemotherapy

January 12, 2015
·
4 min read
Drug Development

Bristol-Myers Squibb Company Release: CheckMate -017, A Phase 3 Study Of Opdivo (Nivolumab) Compared To Docetaxel In Patients With Second-Line Squamous Cell Non-Small Cell Lung Cancer, Stopped Early

January 12, 2015
·
10 min read
Biotech Bay

InnFocus MicroShunt® Continues To Show Excellent Results

January 12, 2015
·
2 min read
Drug Development

Aerie Pharmaceuticals, Inc. Announces Acceleration Of Expected Timeline For Reporting Efficacy Results From Phase 3 Registration Trial (“Rocket 1”) Of Rhopressa

January 12, 2015
·
1 min read
Pharm Country

West Pharmaceutical Services To Present At Upcoming Investor Conference

January 12, 2015
·
1 min read
Deals

SF-Based Genetic Testing Firm Invitae Files for $86 Million IPO

January 12, 2015
·
1 min read
Deals

Down Syndrome Detection Company Ariosa Diagnostics, Inc. Officially Withdraws IPO; Acquired by Roche

January 12, 2015
·
1 min read
Pharm Country

Updated Coverage Report Focuses On Pluristem Therapeutics

January 12, 2015
·
2 min read
Business

10X Genomics Scores $55.5 Million Series B Funding Round

January 12, 2015
·
2 min read